CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Birmingham, Alabama, United States
and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...
Phase 3
Birmingham, Alabama, United States and 185 other locations
Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...
Birmingham, Alabama, United States and 37 other locations
The purpose of this multicentric, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy...
Phase 1, Phase 2
Birmingham, Alabama, United States and 14 other locations
* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advan...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
≥ 18 years with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal...
Phase 1
Birmingham, Alabama, United States and 29 other locations
This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels t...
Phase 1
Birmingham, Alabama, United States and 12 other locations
locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The study will evaluate GI to...
Birmingham, Alabama, United States and 2 other locations
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of...
Phase 1
Birmingham, Alabama, United States and 21 other locations
The study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors. It is thought to work...
Phase 1, Phase 2
Birmingham, Alabama, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal